Objective-Increasing evidence shows that resveratrol has antiatherogenic effects, but its underlying mechanisms are unknown. Thus, we evaluated the molecular mechanisms underlying the antiatherogenic effect of resveratrol. Approach and Results-Using the previously established mouse atherosclerosis model of partial ligation of the left carotid artery, we evaluated the role of resveratrol in antiatherosclerosis. We attempted to determine the mechanisms associated with focal adhesions using vascular endothelial cells. The results showed that resveratrol stimulated focal adhesion kinase cleavage via resveratrol-increased expression of lactoferrin in endothelial cells. Furthermore, we found that an N-terminal focal adhesion kinase fragment cleaved by resveratrol contained the FERM (band 4.1, ezrin, radixin, and moesin)-kinase domain. Furthermore, resveratrol inhibited lipopolysaccharide-stimulated adhesion of THP-1 human monocytes by decreased expression of ICAM-1 (intercellular adhesion molecule-1). A decreased ICAM-1 level was also observed in the left carotid artery of mice treated with resveratrol. To understand the relationship between resveratrol-induced antiinflammation and focal adhesion disruption, endothelial cells were transfected with FERM-kinase. Ectopically expressed FERM-kinase, the resveratrol-cleaved focal adhesion kinase fragment, was found in the nuclear fraction and inhibited the transcription level of icam-1 via the Nrf2 (nuclear factor erythroid 2-related factor 2)-antioxidant response element complex. Finally, ectopically expressed FERM-kinase blocked tumor necrosis factor-α-or IL-(interleukin) stimulated monocytic binding to endothelial cells. Conclusions-Our results show that resveratrol inhibits the expression of ICAM-1 via transcriptional regulation of the FERM-kinase and Nrf2 interaction, thereby blocking monocyte adhesion. These suppressive effects on the inflammatory mechanism suggest that resveratrol delayed the onset of atherosclerosis. Visual Overview-An online visual overview is available for this article. N-terminal FERM (band 4.1 of ezrin, radixin, and moesin) domain; and a tyrosine kinase domain. 4 The tyrosine kinase domain links the other 2 domains. Each domain exhibits a specific activity, with important roles in the overall FAKassociated function. 5 The FRNK domain participates in the recruitment of FAK to FA sites, 6, 7 whereas the FERM domain facilitates FAK shuttle between the cytosol and the nucleus through nuclear export signal sequences and nuclear localization signal sequences. The tyrosine kinase domain controls the localization of FAK via nuclear export signal sequences that are crucial for the nuclear export of FAK.
A therosclerosis is a progressive condition that causes heart disease and stroke. At the earliest stage, monocytes and lymphocytes are recruited to the endothelial lesion of the artery wall, 1 followed by infiltration into tunica intima, generation of various cytokines, and transformation into foam cells. Endothelia, representing physical barriers between blood vessels and tunica media, are critical for monocyte or leukocyte adhesion to vessel walls. Adhesion of monocytes and lymphocytes occurs in an organized manner through various adhesion molecules, including ICAM-1 (intercellular adhesion molecule-1) and VCAM-1 (vascular cell adhesion molecule-1), located on the cell surface.
Adhesion of monocytes and lymphocytes to endothelium is also affected by other associated molecules inside endothelial cells, such as FAK (focal adhesion kinase ). FAK is recruited to sites of focal adhesion (FA), and tightly linked to various structural networks of intracellular cytoskeletons and ECM (extracellular matrix). 2 Functionally, FAK plays a key role in the cross talk between the cytoskeleton and ECM. Given the structural and functional role of FAK in adherens junctions, integrin-mediated desmosomes, and a variety of signaling pathways, FAK is strongly associated with the development of atherosclerosis. 3 FAK comprises an FRNK (FAK-related nonkinase) domain that includes a C-terminal FA targeting domain; an N-terminal FERM (band 4.1 of ezrin, radixin, and moesin) domain; and a tyrosine kinase domain. 4 The tyrosine kinase domain links the other 2 domains. Each domain exhibits a specific activity, with important roles in the overall FAKassociated function. 5 The FRNK domain participates in the recruitment of FAK to FA sites, 6, 7 whereas the FERM domain facilitates FAK shuttle between the cytosol and the nucleus through nuclear export signal sequences and nuclear localization signal sequences. The tyrosine kinase domain controls the localization of FAK via nuclear export signal sequences that are crucial for the nuclear export of FAK. 8 Stimulation of cells with staurosporine and leptomycin B leads to elevated levels of nuclear FAK. [8] [9] [10] In the nucleus, FAK is known to interact with p53, MDB2 (methyl CpG-binding domain protein 2) , and NF1 (neurofibromin 1), which control heterochromatin remodeling and cellular apoptosis. [11] [12] [13] [14] Previously, Lim et al 15 showed that nucleus-localized FAK controls the expression of VCAM-1 in heart vessel-associated endothelial cells in a mouse model. Specifically, this study showed that VCAM-1 inhibition by FAK was mediated by polyubiquitination and degradation of GATA4 (GATAbinding protein 4) because of binding with FAK-FERM in the nucleus, supporting a potential antiinflammatory function of FAK-FERM in a mouse model. VCAM-1 is a membrane protein that mediates monocyte binding to endothelial cells, early in the developmental stage of atherosclerosis, an inflammatory disease. 1 The molecular mechanisms underlying the pathological role of heterotypic cell adhesion have been investigated in many studies. Thus, ICAM-1 was shown to play a major role in heterotypic cell adhesion, in association with VCAM-1. 16 Therefore, it is possible that nuclear FAK plays a role in the expression and avidity of ICAM-1. However, the effect of nuclear FAK on the expression of ICAM-1 remains unclear.
Resveratrol is a phytoalexin naturally found in various plants including grapes. Increasing evidence has shown that resveratrol plays a key role in stimulating antiinflammatory signaling, thus suggesting a protective role against atherosclerosis. 17 In contrast, at high concentrations (50-100 µmol/L), resveratrol induces cellular detachment from cell-ECM junctions, 18 alters cell migration, and disrupts FA. 19, 20 These resveratrol-induced malfunctions are associated with FAK activity, which is controlled by FAK phosphorylation and FAK cleavage. [21] [22] [23] [24] [25] Accordingly, the pharmaceutical mechanism of action of FAK-associated resveratrol in the vascular system has yet to be elucidated.
We hypothesized that resveratrol cleaves FAK and the FAK fragments regulate vascular functions. Our results show that an N-terminal FAK fragment controls the expression of ICAM-1 or VCAM-1, heterotypic cell adhesion between endothelial cells and monocytes, and the development of atherosclerosis.
Materials and Methods
The authors declare that all supporting data are available within the article and in the online-only Data Supplement.
Gene Expression Analysis of Aortic Endothelium in Response to Treatment of Resveratrol Invivo
For studies of gene expression changes in mouse arterial endothelium in response to resveratrol administration, 8-to 9-week-old C57BL/6J mice were randomly divided into 2 group (n=5 per group) based on body weight, to ensure similar distribution between the groups (P>0.05). Mice on normal chow diet were intraperitoneally administrated with either resveratrol (20 mg/kg) or vehicle (10% dimethyl sulfoxide in normal saline) daily, for 8 days before partial ligation. Following pretreatment of resveratrol or vehicle, mice underwent partial carotid ligation surgery as described above. At 48 hours after partial carotid ligation, endothelial-enriched total RNAs were separately collected from the right carotid artery and left carotid artery (LCA) and purified as described previously. 26, 27 Total RNA was reverse transcribed into cDNA using a High Capacity RNA-to cDNA kit (Applied Biosystems, Foster City, CA), and then subjected to quantitative real-time PCR using QuantiFast SYBR Green PCR master mix (Qiagen) with custom-designed specific primers for mouse VCAM-1 (5′-TCTTGGGAGCCTCAACGGTA-3′ and 5′-CAAGTGAGGGCCATGGAGTC-3′ forward and reverse, respectively) and mouse ICAM-1 (5′-GGACTCACCTGCTGGTCTCT-3′ and 5′-CCCCTGCGATCTAGGAATTT-3′ forward and reverse, respectively) on a StepOnePlus Real-Time PCR System (Applied Biosystems). The specific purifiers for 18S (5′-AGGAATTGACG GAAGGGCACCA-3′ and 5′-GTGCAGCCCCGGACATCTAAG-3′ forward and reverse, respectively) were used as a house-keeping control. Each reaction preparation and quantitative real-time PCR were performed as described previously. 28, 29 The fold change between groups was determined for all targets using the 2 ΔΔCt method.
Atherosclerotic Plaque Formation Assessment
This experiment adhered to the guidelines for experimental atherosclerosis studies described in the American Heart Association Statement. 30 We used male mice in this study, because the female hormone estrogen significantly influences the outcome of atherosclerotic studies. [31] [32] [33] For studies of atherosclerotic plaque formation, we employed an acute partial ligation model of atherosclerosis. 26, 27 8-week-old ApoE −/− mice were randomly divided into 2 groups (n=6 per group) based on body weight and were intraperitoneally administrated with either resveratrol (20 mg/kg) or vehicle (10% DMSO in normal saline) daily, for 8 days before partial ligation; these mice were fed a normal chow diet. Following pretreatment of testing samples, mice underwent partial carotid ligation surgery as described above and were maintained on a high-fat Paigen diet (D12336 Research Diets, Inc, New Brunswick, NJ) containing 1.25% cholesterol and 0.5% cholic acid, for 2 weeks. Mice were continuously administrated with resveratrol or vehicle, respectively, until the end of the experiment. Animals were euthanized on the day 14 postligation, by CO 2 NF-κB nuclear factor kappa B Nrf2 nuclear factor erythroid 2-related factor 2 TNF-α tumor necrosis factor-α VCAM-1 vascular cell adhesion molecule-1 gas inhalation. Then, the aorta and carotid arteries were carefully excised, and the surrounding fat tissue was removed by dissection. Aorta and carotid arteries were photographed using a digital microscope device (ToupCam TPH02000A, Hangzhou, China) with a scale bar reference. The opaque area covered by plaque and total artery area of LCA were quantified using NIH ImageJ software as described previously. 28 To visualize atherosclerotic plaque, LCA and right carotid artery tissues were embedded in Tissue-Tek optimal cutting temperature compound (Sakura Finetek, Torrance, CA), and cryosections (7 μm) were prepared and oil-red-O staining of tissue sections was performed. Then, micrographs were taken with a light microscope at ×10 magnification and images were analyzed with National Institutes of Health ImageJ software. Atherosclerotic lesion area and plaque size were calculated as described previously. 28 An expanded Materials and Methods section is available in the online-only Data Supplement.
Results

Resveratrol Inhibits the Development of Atherosclerosis
To determine whether resveratrol administration affected vascular inflammation and atherosclerosis in arteries, we used an established mouse model of vascular inflammation and atherosclerosis induced by the partial ligation on the LCA. 26, 34 The results showed that rapid plaque formation was observed on the LCA in the control group (no resveratrol) of ApoE −/− mice, 2 weeks after ligation on a high-fat diet, although the contralateral right carotid artery remained lesion-free ( Figures 1A  through 1C) . Notably, however, plaques in the LCA of resveratrol-treated ApoE −/− mice were significantly less compared with those of the control mice ( Figure 1A ). The result of Oilred-O staining on the LCA showed that resveratrol substantially decreased fat deposition by 50 % to 70% ( Figures 1B  and 1C ). These data suggest that resveratrol has potent antivascular inflammation and antiatherogenic properties.
Resveratrol Induces FAK Cleavage, Thereby Blocking Cell-to-ECM Adhesion
To understand the molecular mechanisms underlying the antiatherogenic effect of resveratrol, we examined the effect of resveratrol on cell-to-ECM adhesion using endothelial cells. We first observed that the plasma level of resveratrol was ≈500 nmol/L when resveratrol was injected as above ( Figure  I in the online-only Data Supplement). Pretreatment with 500 nmol/L resveratrol inhibited cell-to-ECM adhesion, whereas both LPS and TNF-α (tumor necrosis factor-α), proinflammatory agents, had no effect (Figures 2A and 2B ). Although LPS was used as a general proinflammatory agent, TNF-α was used to stimulate inflammatory signaling associated with atherosclerosis in vitro, because this cytokine was strongly correlated with partial ligation-induced mouse atherosclerosis development. 28, 35, 36 We then examined the changes in the expression of ECM-associated molecules, integrins, and FAK, by resveratrol pretreatment. The protein levels of integrin α5, α6, and αvβ3 remained the same ( Figure 2C ). However, pretreatment of bovine aortic endothelial cells (BAECs) and mouse aortic endothelial cells with resveratrol led to FAK cleavage ( Figures 2C and 2D , and Figure IIA in the onlineonly Data Supplement). Consistently, in C57BL/6 mice, intraperitoneal injection of resveratrol enhanced the degree of FAK cleavage in the blood vessel compared with sham injection ( Figure 2E ). In conclusion, resveratrol induces FAK cleavage in vitro and in vivo, affecting cell-to-ECM adhesion.
We further examined the mechanism for resveratrolstimulated FAK cleavage in endothelial cells. First, we found that resveratrol activated proteases in BAECs and mouse aortic endothelial cells ( Figure IIB in the online-only Data Supplement), suggesting that FAK cleavage occurred via resveratrol-activated protease(s). Thus, in a series of experiments, we determined the resveratrol-induced cleavage site of FAK. Treatment of endothelial cells with 100 µmol/L resveratrol resulted in the appearance of a new band of ≈80 kDa in western blots probed with FAK antibody ( Figure IIC in the online-only Data Supplement). This band could be an FAK fragment containing part of the FERM and kinase domains, because the FAK antibody used in this study only detected the middle portion of the FERM domain. 37 To precisely determine whether the fragment contained the full FERM domain, we constructed a recombinant protein containing mFAKv (N-terminal myc and C-terminal V5). In BAECs transfected with the mfakv gene, the cleaved fragment contained the N-terminal c-Myc tag ( Figure 2F ), indicating that the fragment cleaved by resveratrol carried both intact FERM and kinase domains. Using the Protease Substrate Prediction tool, we predicted FAK cleaving proteases as tryptase β, elastase Resveratrol cleaves FAK (focal adhesion kinase) after long-term starvation. A, Bovine aortic endothelial cells (BAECs) were pretreated with 100 µmol/L resveratrol (Res) or 100 ng/mL lipopolysaccharide (LPS) for 0-12 h. Cells were detached with 4 mmol/L EDTA and re-plated in wells of a 96-well plate and incubated for 1 h at 37°C. After unattached cells were washed away, the attached cells were stained with 0.2% crystal violet, harvested, and quantified by measuring optical densities at 570 nm. Line graphs represent mean±SEM (n=5; *P<0.05, Mann-Whitney U test). B, BAECs were pretreated with 10 ng/mL TNF-α (tumor necrosis factor-α or 500 nmol/L Res for 12 h. Then, extracellular matrix (ECM) adhesion was performed as described in (A; *P<0.05, KruskalWallis test followed by Dunn test). C, BAECs were treated with Res (100 µmol/L) for 0-12 h. Cell lysates were obtained and immunoblotted with antiFAK (epitope residues 1-423) or indicated antibodies. Bar graphs represent mean±SEM (n=3; *P<0.05, Kruskal-Wallis test followed by Dunn test). D, BAECs were treated with various concentrations of Res and immunoblotted as described in (B). Bar graphs represent mean±SEM (n=3; *P<0.05, 1-way ANOVA (ANOVA) followed by Tukey test). E, Res (20 mg/kg) or sham was intraperitoneally injected in male C57BL/6 mice daily for 1 wk. The abdominal aorta was extracted and lysed with lysis buffer. Lysates were immunoblotted. Bar graphs represent mean±SEM (n=5; *P<0.05, Mann-Whitney U test). F, BAECs were transfected with a vector encoding mFAKv (N-terminal c-Myc-tagged and C-terminal V5-tagged FAK), and then treated with 100 µmol/L Res for 12 h. Res-treated cells were harvested and lysed by sonication in PBS. Subsequently, immunoblots were obtained using antibodies against c-Myc, V5, and FAK. G, Mouse aortic endothelial cells (MAECs) were transfected with FAKv and immunoprecipitated with V5 antibody. Immunoprecipitated complexes were incubated with 200 µg/ mL lactoferrin overnight. Immunoblots were performed using antiFAK and antiV5 antibodies. WB indicates Western blot.
2, kallikrein 1, thrombin, and lactoferrin ( Figure IID in the online-only Data Supplement). Intriguingly, lactoferrin is known as a novel predictor of ischemic heart disease. 38 Based on this cardiovascular function of lactoferrin, we performed experiments to determine if lactoferrin cleaved FAK. As shown in Figure 2G , lactoferrin appeared to truncate FAK, producing an ≈80 kDa fragment. It was also found that resveratrol increased the expression of lactoferrin in endothelial cells ( Figure IIE in the online-only Data Supplement), indicating that resveratrol cleaved FAK via lactoferrin.
Ectopically Expressed FERM-Kinase in Endothelial Cells Is Mostly Located in the Nuclear Fraction
The resveratrol-produced fragment was evenly distributed in the nuclear and cytosolic fractions ( Figure 3A) . To determine the role of resveratrol-produced FAK fragments containing the FERM and kinase domains, we constructed an FRNKdeleted FAK mutant designated as FERM-kinase ( Figure 3B ). Other FAK mutants, including FAKv (C-terminal V5 tagged FAK), kinase, and FRNK ( Figure 3B ), were also used as controls. We confirmed that FAKv, kinase, FRNK, and FERMkinase were sufficiently expressed in BAECs ( Figure 3B ). In addition, ectopically expressed FAKv and FERM-kinase were observed in both nuclear and cytosolic fractions under serum-starved conditions ( Figure 3C ). However, the kinase and FRNK were observed in the cytosol exclusively ( Figure 3C ), consistent with previous reports, 15, 39 although a substantial fraction of FERM-kinase was observed in the nucleus of BAECs and mouse aortic endothelial cells compared with FAKv ( Figure 3C and Figure III in the online-only Data Supplement). These results support a potential mechanism of FAKv recruitment to FA through FRNK, which is the domain that is essential for FA recruitment. 19 Moreover, these results confirm our previous results showing the presence of resveratrol-produced FAK fragments in the nuclear fraction. We further found that FERM-kinase had no effect on nuclear translocation of various nuclear factors such as NF-κB (nuclear factor kappa B) and signal transducers and activators of transcription ( Figure IV in the online-only Data Supplement).
Resveratrol Blocks LPS-Stimulated Monocyte Binding to Endothelial Cells by Inhibiting ICAM-1 Expression
It is well known that chronic endothelial inflammation contributes to atherosclerosis development. Therefore, in this study, we used LPS as a potent stimulus to induce endothelial cell inflammatory responses. To examine the role of resveratrol in LPS-stimulated inflammation, we used a THP-1 human monocyte adhesion assay. The result showed that resveratrol or FERM-kinase substantially inhibited THP-1 adhesion to BAECs (30%-40%, 12 hours after treatment with resveratrol; Figure 4A and Figure VA in the onlineonly Data Supplement). More convincingly, we found that FERM-kinase overexpression did not reverse cell adhesion reduced by FAK knockdown (Figures VB through VD in the online-only Data Supplement). These results suggest that the cleavage of FAK is causative for reduced cell adhesion. To explore the molecular mechanisms associated with the inhibitory effect of resveratrol on monocyte adhesion, the levels of ICAM-1, VCAM-1, and PECAM-1 (platelet and endothelial cell adhesion molecule 1) were measured in endothelial cells after treating with resveratrol. Resveratrol reduced the protein levels of ICAM-1 significantly more than VCAM-1 or PECAM-1 ( Figure 4B ). The inhibited expression of ICAM-1 by resveratrol was still observed in endothelial cells 6 hours after resveratrol treatment (≈60%; Figure VIA in the onlineonly Data Supplement). These data were consistent with previous reports. [27] [28] [29] Promoter assays also showed that resveratrol inhibited the transcriptional activity of the icam-1 gene ( Figure 4C and Figure VIB in the online-only Data Supplement). Additionally, to determine whether resveratrolinhibited icam-1 transcription occurs in in vivo, we examined the icam-1 mRNA level in endothelial cells obtained from partially ligated LCA and nonligated right carotid artery in mice administrated with vehicle and resveratrol. The results showed that ligation-enhanced expression of icam-1 was significantly decreased in the resveratrol-treated group compared with that of the vehicle-treated group ( Figure 4D ). Together, these results suggest that resveratrol prevents 
Ectopically Expressed FERM-Kinase Inhibits ICAM-1 Expression via Interaction Between FERM-Kinase and Antioxidant Response Element/Nrf2
To determine the effects of resveratrol on endothelial FA and inflammatory responses, sequentially and systematically, we examined if the expression of icam-1 was regulated by FERMkinase overexpression in endothelial cells. For this study, we constructed a vector carrying the promoter gene of icam-1 and the firefly luciferase gene. BAECs were cotransfected with this vector, a vector containing the fak mutant gene, or a vector containing the renilla luciferase gene to perform icam-1 promoter assays. Overexpression of FERM-kinase and FAKv inhibited the expression of icam-1 ( Figure 5A ). However, 2 mutants (kinase and FRNK) had no effect on icam-1 expression. This result was associated with the nuclear localization signal sequences located in the FERM domain. Moreover, the inhibitory effect of FERM-kinase was greater than that of FAKv by 1.4-fold ( Figure 5A ). The lower effect of FAKv may have been attributed to an effect of the C-terminal FRNK domain of FAKv on the recruitment of FAKv to FA, which hampered the nuclear translocation of FAKv.
To ascertain the promoter region of icam-1 associated with FERM-kinase, we constructed serially deleted promoters during the promoter assays. Transcriptional activity of SD3 increased significantly more than that of SD2 ( Figure 5B ), indicating that a deletion of the −991 to −879 bp region played a key role in the transcriptional activity of icam-1. To identify inhibitory mechanisms of this region, we examined whether FERM-kinase was associated with the −991 to −879 bp region of the promoter. Using the combined approach of PCR and immunoprecipitation as described in the Materials and Methods, we found that FERM-kinase interacted with the −991 to −879 bp promoter region of icam-1 ( Figure 5C ). This interaction was confirmed by chromatin-immunoprecipitation ( Figure 5D ). Moreover, the region contained antioxidant response element (ARE; GCnnnC/GTCA) from −961 to −953 bp. 40 Hence, ARE interacts with a transcriptional factor called Nrf2 (nuclear factor erythroid 2-related factor 2) 41 ; we 
FERM-Kinase Inhibits ICAM-1 Expression and Heterotypic Cell Adhesion Between Monocytes and Endothelial Cells
Following the results of the FERM-kinase/Nrf2 inhibitory effects on icam-1 transcription, we examined the effect of FERM-kinase on endothelial cell function by evaluating monocyte adhesion. The results showed that FERM-kinase . FERM (band 4.1, ezrin, radixin, and moesin)-kinase reduces the expression of intercellular adhesion molecule-1 (ICAM-1) via nuclear factor erythroid 2-related factor 2/ antioxidant response element (Nrf2/ARE) and THP-1 cell adhesion to bovine aortic endothelial cells (BAECs). A, BAECs were cotransfected with vectors containing icam-1 promoter-linked luciferase gene, renilla gene, various fak, or its mutant genes. Subsequently, the transcriptional activity of icam-1 was measured by promoter assay. Bar graphs show mean±SEM (n=4; *P<0.05, Kruskal-Wallis test followed by Dunn test). B, BAECs were cotransfected with vectors containing serially deleted icam-1 promoter-linked luciferase genes, renilla gene, and ferm-kinase gene. Promoter activity was determined as described in (A). C, Double-stranded DNA fragments (−991 to −879 bp) were polymerized by polymerase chain reaction (PCR). The DNA fragments were incubated with a cell lysate derived from BAECs transfected with various fakv or its mutant genes. The mixtures were coimmunoprecipitated with an anti-V5 antibody. Immunoprecipitants were assayed by Western blotting analysis and additional PCR. D, Mouse aortic endothelial cells (MAECs) were transfected with ferm-kinase and then fixed with 1% formaldehyde. Cells were lysed by sonication and then immunoprecipitated using mouse IgG or anti-V5 antibody. Then, DNA fragments were isolated by ethanol precipitation after reverse-crosslinking was performed. Isolated DNA fragments were used for quantitative PCR (qPCR). Data are plotted as bar graphs (mean±SEM, n=3; *P<0.05, Mann-Whitney U test). E, Immunoprecipitants were blotted by anti Nrf2 (nuclear factor erythroid 2-related factor 2) antibody. F, BAECs were transfected with vectors containing nrf2 gene or none. The promoter assay was performed as described in (B). Bar graphs represent mean±SEM (n=4; *P<0.05, 1-way ANOVA with followed by Tukey test). G, BAECs were transfected with or without scrambled or siNrf2 with vectors containing none or ferm-kinase gene. The promoter assay was executed as described (B). Data are plotted as bar graphs (mean±SEM, n=5; *P<0.05, Kruskal-Wallis test followed by Dunn test). Immunoblots were also performed using antibodies against V5, Nrf2, and actin. FAKv indicates C-terminal V5 tagged FA; FRNK, FAK-related nonkinase; siRNA, small interfering RNA; and WB, Western blot.
significantly inhibited heterotypic cell adhesion between BAECs and THP-1 cells, whereas the other constructs had no effect ( Figure 6A) . Surprisingly, FAKv had no effect on THP-1 cell adhesion, although FAKv inhibited the expression of icam-1, suggesting that endogenous ICAM-1 was not affected by FAKv ( Figure 5A ). Endogenous ICAM-1 in control cells remained effective in heterotypic cell adhesion, which attenuated the signal-to-noise ratio of FAKv. In addition, the lack of inhibitory effect of FAKv on heterotypic cell adhesion was possible because of the minimal effect of FAKv. In comparison, the inhibitory effect of FERM-kinase was remarkable, indicating that FERM-kinase was more effective than FAKv.
The inhibitory effect of FERM-kinase on ICAM-1 expression was confirmed by Western blotting and promoter assays in TNF-α-treated BAECs ( Figure 6B and 6C) . 
Discussion
The molecular function of resveratrol in cardiovascular health and diseases remains unknown. The current study identified the molecular mechanism of resveratrol specifically on FA and heterotypic cell adhesion using vascular aortic endothelial cells, monocytes, and mouse atherosclerosis models. Resveratrol appeared to stimulate cleavage of cytosolic FAK to an FRNK-deleted form and translocated FAK to the nucleus. Such alterations of FAK in the cytoplasm and nucleus by resveratrol affect the interaction between cytosolic FAK and a variety of molecules, including integrins, Src kinase, p130Cas, paxillin, caveolin-1, and endothelial nitric oxide synthase. [42] [43] [44] [45] Meanwhile, nuclear FAK or its cleaved fragments interact with additional transcriptional factors, such as p53, 39 thereby regulating gene expression. Thus, resveratrolinduced cleaved FAK plays a central role in inhibiting icam-1 expression and heterotypic cell adhesion. Our current findings suggest that nuclear FAK, specifically nuclear FERM-kinase, but not cytosolic FAK, plays a predominant role in the expression of icam-1 or vcam-1 in endothelial cells.
In endothelial cells, FAK is a key factor at FA sites in the control of angiogenesis, endothelial barrier function, and mechanotransduction. 5, 46, 47 Most FAK functions are closely linked to molecular and functional roles of FAK in cellcell and cell-ECM junctions. In this study, FAK fragments (FERM-kinase) cleaved by resveratrol-enhanced lactoferrin were detached from FA and played a role in junction-independent cellular function. Lactoferrin was recently found to exhibit anti-inflammatory activity via suppression of icam-1 expression. 48 However, the vascular functions of intracellular lactoferrin are not entirely clear. We found that intracellular Figure 4 . Quantified data were plotted as bar graphs (mean±SEM, n=3; *P<0.05, KruskalWallis test followed by Dunn test). B and C, BAECs transfected with vector and ferm-kinase were treated with or without 10 ng/mL TNF-α (tumor necrosis factor-α). Immunoblotting (B) and promoter assay (C) were conducted. Bar graphs represent mean±SEM (n=3; *P<0.05, Mann-Whitney U test). D, THP-1 cell adhesions to BAEC were analyzed as described in Figure 4 . BAECs were treated with or without 100 ng/mL lipopolysaccharide (LPS) or 10 ng/mL TNF-α Bar graphs represent mean±SEM (n=3; *P<0.05, Mann-Whitney U test). E, Human umbilical vein endothelial cells transfected with vector and ferm-kinase were treated with or without 10 ng/mL TNF-α. The THP-1 cell adhesions were analyzed. Bar graphs represent mean±SEM (n=3; *P<0.05, Mann-Whitney U test). FAKv indicates C-terminal V5 tagged FA; FRNK, FAK-related nonkinase; and WB, Western blot.
lactoferrin acts as an antiinflammatory agent via FAK cleavage in vascular endothelial cells. Furthermore, we found that nuclear location of FERM-kinase was substantially elevated. FERM-kinase is an FRNK-deleted FAK fragment that is located at nonjunctional regions, for example, cytosol or nucleus. 19 Nonjunctional nuclear FAK inhibits TNF-α-induced vcam-1 expression by binding and blocking transcription factor GATA4. 15 Similarly, we also found that FERM-kinase and nonjunctional FAK play an important role in maintaining endothelial cellular functions by inhibiting monocyte recruitment via inhibition of cell adhesion molecules ( Figure 6 ). Our finding on an inhibitory function of FERM-kinase in monocyte binding to endothelial cells is consistent with the previous mouse study by Lim et al 15 , which showed that FAK-FERM plays a key role in anti-inflammation. Although many studies using the vascular cell model have contributed to our understanding of the mechanism of early atherosclerosis, 29 we recognize that cell models do not recapitulate in vivo pathogenesis of atherosclerosis. To overcome the limitations of the current study using a vascular cell model, a transgenic mouse model of FERM-kinase overexpression is needed to test the in vivo function of FERM-kinase in atherosclerosis. Thus, further studies using such an in vivo model are warranted.
Interestingly, the molecular mechanism of resveratrolinhibited transcription of cell adhesion molecules (ICAM-1 and VCAM-1) involves both FERM-kinase and Nrf2. The FERMkinase domain interacted with the Nrf2 complex to inhibit transcription via the ARE site Figure 4C ). Since both mouse icam-1 and mouse vcam-1 promoters contain ARE sequences, the inhibitory effect of FERM-kinase on the expression of these genes was observed. Our study also showed that this inhibition requires interaction between FERM-kinase and Nrf2. Nrf2-dependent downregulation of icam-1 expression has been previously shown to be mediated by NF-κB inactivation, 49 suggesting a mechanistic model of Nrf2/FERM-kinase-mediated inhibition of icam-1 expression via NF-κB inactivation (Graphic Abstract). Nrf2 plays an important role in protecting against left ventricle hypertrophy, fibrosis, apoptosis, and heart failure. 50 This protection occurs via modulation of the expression of a variety of antioxidant/oxidant genes in cardiomyocytes. 51 Given that multiple cardiovascular diseases are associated with oxidative stress, it is conceivable that the Nrf2-associated signaling pathway plays an important role in preventing atherosclerosis. Considering the critical role of Nrf2 signaling, our findings suggest that nuclear FERM-kinase is a potential atheroprotective molecule regulating the transcriptional activity of Nrf2. Our findings are supported by previous observations suggesting that resveratrol enhances the Nrf2 function. 52 In conclusion, the current study demonstrates resveratrolstimulated antiinflammatory and antiatherogenic responses by the molecular mechanism involving the interaction between FERM-kinase and Nrf2, which inhibits icam-1 transcription. Future studies are needed to not only investigate other genes regulated by the FERM-kinase/Nrf2 complex and their role in oxidative stress, but also to elucidate other partner proteins of FERM-kinase that regulate genes in the nucleus.
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